Skip to content

Utility of Placental/Umbilical Cord Blood in Early Onset Neonatal Sepsis in Very Low Birth Weight Infants

A Pilot Study to Evaluate the Utility of Placental/Umbilical Cord Blood (PUCB) in Early Onset Neonatal Sepsis (EONS) in Very Low Birth Weight Infants

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03694613
Enrollment
65
Registered
2018-10-03
Start date
2019-06-01
Completion date
2020-08-20
Last updated
2021-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Early-Onset Neonatal Sepsis, Preterm Infant, Umbilical Cord

Keywords

Preterm Infant, Early-Onset Neonatal Sepsis, Umbilical Cord, Complete Cell Count, Placenta, Blood Culture

Brief summary

This study evaluates the utility of placental/umbilical cord blood (PUCB) to perform the baseline workup testing for EONS in Very Low Birth Weight Infants: CBC (Complete Blood Count) with differential, Immature/Total ratio (I/T ratio), and blood culture along with CRP and IL-6 levels. A cohort (63 subjects) of preterm infants will be recruited. All the participants will be evaluated for sepsis using placental/umbilical cord blood (PUCB) and subject blood sample during the first 12 hours of life (after birth).

Detailed description

Early Onset Neonatal Sepsis (EONS) is common in preterm infants, and it is associated with high morbidity and mortality, especially if not diagnosed early. Currently the baseline workup is done using blood samples from the infant to perform Blood culture, CBC, I/T ratio. These tests have shown to have low sensitivity and specificity to diagnosis EONS. PUCB can be another safe source of blood which is useful, painless and simple to collect. As CBC, I/T ratio and blood culture may not be enough to diagnose EONS we will add IL-6 and CRP which will increase sensitivity and specificity to diagnose EONS in preterm infants without collecting blood from the infants. This study may be a step to decrease iatrogenic blood loss to diagnose EONS. The primary outcome of the current research will be to find out the utility of PUCB in diagnosing EOS in preterm infants (\<30 weeks and \<1250 grams birth weight). Using PUCB can increase the accuracy to diagnose Sepsis in Preterm infants, and it will also conserve blood in the extremely premature infants while reducing hemodynamic instability due to acute blood loss.

Interventions

OTHERPlacental/Umbilical Cord Blood sample

After infant is delivered, placenta along with clamped umbilical cord Blood will be obtained from the ObGyn team. One umbilical clamp will be placed at the umbilical end, and the other clamp will be placed on the placental end of the umbilical cord. Then the umbilical cord will be cut between the clamps. The umbilical cord will be cleaned three times with 2% chlorhexidine, plus 70% isopropyl alcohol under sterile conditions (sterile gloves). Cord blood samples will be collected using vacutainer blood collecting system with a sterile 22-gauge needle. We will collect 3 - 4 ml of blood.

Sponsors

The University of Texas Medical Branch, Galveston
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Masking description

Clinical team (care provider) will be blinded to the Placental/Umbilical Cord Blood sepsis evaluation results

Eligibility

Sex/Gender
ALL
Age
No minimum to 1 Days
Healthy volunteers
No

Inclusion criteria

* Infants \<34 weeks' gestational

Exclusion criteria

* Known congenital or chromosomal anomalies * Congenital heart disease (other than Patent Ductus Arteriosus, Patent Foramen Ovale or Atrial Septum Defect) * Vaginal bleeding at admission

Design outcomes

Primary

MeasureTime frameDescription
White Blood Cell Count (WBC) (1)Completed during the first 30 minutes after birth. This sample is going to be taken from the discarded Placental/umbilical blood cord.Normal Range approximately 6,000 - 30,000 cell/mm3.
White Blood Cell Count (WBC) (1) INFANT BLOODCompleted during the first 6 hours after birth. This sample is going to be taken directly from the participant.Normal Range: 6.000 - 30.000 cell/mm3.
I/T Ratio (Immature/Total Immature Neutrophil).I/T Ratio Was Calculated by Dividing Immature White Cell Count Total White Cell CountCompleted during the first 30 minutes after birth. This sample is going to be taken from the discarded Placental/umbilical blood cord.Normal Range of I/T ratio: \<0.2.
I/T Ratio (Immature/Total Immature Neutrophil Ratio) INFANT BLOODCompleted during the first 12 hours after birth. This sample is going to be taken directly from the participant.Normal Range: \<0.2
CRP (C-Reactive Protein)(1)Completed during the first 30 minutes after birth. This sample is going to be taken from the discarded Placental/umbilical blood cord.Normal Range: \< 10,000 ng/mL
CRP (C-Reactive Protein)(2) INFANT BLOODCompleted during the first 6 hours after birth. This sample was taken directly from the participant.Normal Range: \<10.000ng/mL
IL-6 (1)Completed during the first 30 minutes after birth. This sample is going to be taken from the discarded Placental/umbilical blood cord.Normal Range: 0-10.2 pg/ml
IL-6 (Interleukin-6) INFANTS BLOODCompleted during the first 6hours after birth. This sample is going to be taken directly from the participant.Normal Range: \<100 pg/mL
Procalcitonin PUBCWithin 30 minutes after deliveryBlood was taken from PUBC after delivery
Procalcitonin Level Was Measured in the Blood From Placenta and From the Baby Within 6 Hours After BirthProcalcitonin Level was measured in the blood from placenta and in Infant's Blood (within 6 hours)Procalcitonin levels
Number of Participants With Negative Blood Culture From Blood Drawn From Placenta and From Baby Within 6 Hours After BirthBlood sample drawn from placenta and from baby within 6 hours after birth.Normal Range: Blood Culture Negative
Presepsin- PUBCFirst 30 min after birthPresepsin level was measured in the blood drawn from placenta and from the baby within 6 hours after birth
Presepsin-Infant's BloodFirst 30 min after birthLevels of presepsin
Number of Participants With a Negative Blood Culturefirst 2 hours after birthBlood is taken from infants after birth

Countries

United States

Participant flow

Recruitment details

Subjects were recruited at the Neonatal Intensive Care of the University of Texas Medical Branch, Galveston, Texas.

Pre-assignment details

We included 65 PI \<34 weeks, who were screened for EOS and admitted to the NICU (June 2019 to June 2020). Infants with known lethal chromosomal or congenital anomalies were excluded.

Participants by arm

ArmCount
Placental/Umbilical Cord Blood Sample
Placental/Umbilical Cord Blood sample will be collected after delivery from every participant. Plancental/Umbilical Cord Blood sample: After infant is delivered, placenta along with clamped umbilical cord Blood will be obtained from the ObGyn team. One umbilical clamp will be placed at the umbilical end, and the other clamp will be placed on the placental end of the umbilical cord. Then the umbilical cord will be cut between the clamps. The umbilical cord will be cleaned three times with 2% chlorhexidine, plus 70% isopropyl alcohol under sterile conditions (sterile gloves). Cord blood samples will be collected using vacutainer blood collecting system with a sterile 22-gauge needle. We will collect 3 - 4 ml of blood.
65
Total65

Baseline characteristics

CharacteristicPlacental/Umbilical Cord Blood Sample
Age, Continuous32.15 Weeks
STANDARD_DEVIATION 2.21
Birth weight1853 grams
STANDARD_DEVIATION 519
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
2 Participants
Race (NIH/OMB)
Black or African American
10 Participants
Race (NIH/OMB)
More than one race
12 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
White
41 Participants
Region of Enrollment
United States
65 participants
Sex: Female, Male
Female
27 Participants
Sex: Female, Male
Male
38 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 65
other
Total, other adverse events
0 / 65
serious
Total, serious adverse events
0 / 65

Outcome results

Primary

CRP (C-Reactive Protein)(1)

Normal Range: \< 10,000 ng/mL

Time frame: Completed during the first 30 minutes after birth. This sample is going to be taken from the discarded Placental/umbilical blood cord.

ArmMeasureValue (MEAN)Dispersion
Placental/Umbilical Cord Blood SampleCRP (C-Reactive Protein)(1)413 ng/mLStandard Deviation 1229
Primary

CRP (C-Reactive Protein)(2) INFANT BLOOD

Normal Range: \<10.000ng/mL

Time frame: Completed during the first 6 hours after birth. This sample was taken directly from the participant.

ArmMeasureValue (MEAN)Dispersion
Placental/Umbilical Cord Blood SampleCRP (C-Reactive Protein)(2) INFANT BLOOD785 ng/mLStandard Deviation 1846
Primary

IL-6 (1)

Normal Range: 0-10.2 pg/ml

Time frame: Completed during the first 30 minutes after birth. This sample is going to be taken from the discarded Placental/umbilical blood cord.

ArmMeasureGroupValue (MEAN)Dispersion
Placental/Umbilical Cord Blood SampleIL-6 (1)PUCB61.45 ng/mLStandard Deviation 392.7
Placental/Umbilical Cord Blood SampleIL-6 (1)INFANT BLOOD45.36 ng/mLStandard Deviation 182.3
Primary

IL-6 (Interleukin-6) INFANTS BLOOD

Normal Range: \<100 pg/mL

Time frame: Completed during the first 6hours after birth. This sample is going to be taken directly from the participant.

Population: Blood was taken from all 65 Infants from placenta and from baby 6 hours after birth

ArmMeasureValue (MEAN)Dispersion
Placental/Umbilical Cord Blood SampleIL-6 (Interleukin-6) INFANTS BLOOD45.36 pg/mLStandard Deviation 182.3
Primary

I/T Ratio (Immature/Total Immature Neutrophil).I/T Ratio Was Calculated by Dividing Immature White Cell Count Total White Cell Count

Normal Range of I/T ratio: \<0.2.

Time frame: Completed during the first 30 minutes after birth. This sample is going to be taken from the discarded Placental/umbilical blood cord.

ArmMeasureValue (MEAN)Dispersion
Placental/Umbilical Cord Blood SampleI/T Ratio (Immature/Total Immature Neutrophil).I/T Ratio Was Calculated by Dividing Immature White Cell Count Total White Cell Count0.09 Ratio of Immatures/Total neutrophilsStandard Deviation 0.13
Primary

I/T Ratio (Immature/Total Immature Neutrophil Ratio) INFANT BLOOD

Normal Range: \<0.2

Time frame: Completed during the first 12 hours after birth. This sample is going to be taken directly from the participant.

ArmMeasureValue (MEAN)Dispersion
Placental/Umbilical Cord Blood SampleI/T Ratio (Immature/Total Immature Neutrophil Ratio) INFANT BLOOD0.12 Immatures/Total neutrophils ratioStandard Deviation 0.13
Primary

Number of Participants With a Negative Blood Culture

Blood is taken from infants after birth

Time frame: first 2 hours after birth

Population: A negative blood culture indicates no infection

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Placental/Umbilical Cord Blood SampleNumber of Participants With a Negative Blood Culture65 Participants
Primary

Number of Participants With Negative Blood Culture From Blood Drawn From Placenta and From Baby Within 6 Hours After Birth

Normal Range: Blood Culture Negative

Time frame: Blood sample drawn from placenta and from baby within 6 hours after birth.

Population: 65 out of 65 subjects were reported to have NEGATIVE blood cultures

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Placental/Umbilical Cord Blood SampleNumber of Participants With Negative Blood Culture From Blood Drawn From Placenta and From Baby Within 6 Hours After Birth65 Participants
Primary

Presepsin-Infant's Blood

Levels of presepsin

Time frame: First 30 min after birth

ArmMeasureValue (MEAN)Dispersion
Placental/Umbilical Cord Blood SamplePresepsin-Infant's Blood5.3 ng/mLStandard Deviation 2
Primary

Presepsin- PUBC

Presepsin level was measured in the blood drawn from placenta and from the baby within 6 hours after birth

Time frame: First 30 min after birth

ArmMeasureValue (MEAN)Dispersion
Placental/Umbilical Cord Blood SamplePresepsin- PUBC4.6 ng/mLStandard Deviation 1.6
Primary

Procalcitonin Level Was Measured in the Blood From Placenta and From the Baby Within 6 Hours After Birth

Procalcitonin levels

Time frame: Procalcitonin Level was measured in the blood from placenta and in Infant's Blood (within 6 hours)

ArmMeasureValue (MEAN)Dispersion
Placental/Umbilical Cord Blood SampleProcalcitonin Level Was Measured in the Blood From Placenta and From the Baby Within 6 Hours After Birth131.4 pg/mLStandard Deviation 411.7
Primary

Procalcitonin PUBC

Blood was taken from PUBC after delivery

Time frame: Within 30 minutes after delivery

Population: PUBC from all 65 subjects recruited

ArmMeasureValue (MEAN)Dispersion
Placental/Umbilical Cord Blood SampleProcalcitonin PUBC185.9 pg/mLStandard Deviation 374
Primary

White Blood Cell Count (WBC) (1)

Normal Range approximately 6,000 - 30,000 cell/mm3.

Time frame: Completed during the first 30 minutes after birth. This sample is going to be taken from the discarded Placental/umbilical blood cord.

ArmMeasureValue (MEAN)Dispersion
Placental/Umbilical Cord Blood SampleWhite Blood Cell Count (WBC) (1)8257 ratio of cells/mm3Standard Deviation 2966
Primary

White Blood Cell Count (WBC) (1) INFANT BLOOD

Normal Range: 6.000 - 30.000 cell/mm3.

Time frame: Completed during the first 6 hours after birth. This sample is going to be taken directly from the participant.

Population: Infant blood taken from 65 subjects after birth

ArmMeasureValue (MEAN)Dispersion
Placental/Umbilical Cord Blood SampleWhite Blood Cell Count (WBC) (1) INFANT BLOOD7055 ratio of cells/mm3Standard Deviation 12400

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026